-
April 23, 2024
Int
New
Seminar schedule has been updated.
-
April 8, 2024
Int
E-learning material is updated
-
March 28, 2024
Int
PMDA Updates (March, 2024) posted
-
December 13, 2023
Int
HBD East 2023 Think Tank Meeting
-
October 12, 2023
Int
ICMRA statement on the safety of COVID-19 vaccines
-
October 12, 2023
Int
ICMRA (International Coalition of Medicines Regulatory Authorities) updated
-
May 26, 2023
Int
Cooperation between WHO and PMDA on training for regulatory authorities
-
October 21, 2022
Int
A Regulatory Pharmaceutical Quality Knowledge Management System (PQ KMS) to Enhance the Availability of Quality Medicines
-
September 12, 2022
Int
PMDA-ATC digital book is now available.
-
May 27, 2022
Int
Statement for healthcare professionals: How COVID-19 vaccines are regulated for safety and effectiveness (Revised 17 May 2022)
-
December 28, 2021
Int
ICMRA Statement on Need for Continued Focus on COVID-19 Therapeutics
-
November 18, 2021
Int
ICMRA AMR campaign is in progress, November 18 to 24, 2021.
-
June 17, 2021
Int
Global Pharmaceutical Quality Knowledge Management: Enhancing Regulatory Reliance and Agility
-
June 17, 2021
Int
Statement for healthcare professionals: How COVID-19 vaccines are regulated for safety and effectiveness (Revised 11 June 2021)
-
June 17, 2021
Int
Joint Statement on transparency and data integrity International Coalition of Medicines Regulatory Authorities (ICMRA) and the World Health Organization (WHO)
-
April 27, 2021
Int
NCC was endorsed to become joint formal CoE with PMDA for "MRCT/GCP inspection" PWA by APEC-LSIF-RHSC.
-
January 19, 2021
Int
ICMRA statement for healthcare professionals: How COVID-19 vaccines will be regulated for safety and effectiveness
-
December 7, 2020
Int
Statement on continuation of vaccine trials
-
December 1, 2020
Int
Statement from Global Medicines Regulators on the Value of Regulatory Reliance
-
November 20, 2020
Int
EMA-FDA and PMDA GCP Pilot Collaboration Report posted
-
November 16, 2020
Int
WHO-ICMRA joint statement on the need for improved global regulatory alignment on COVID-19 medicines and vaccines
-
November 16, 2020
Int
ICMRA meeting: COVID-19 Real-World Evidence and Observational studies #4
-
October 12, 2020
Int
PMDA Reveals Principles on Evaluation of COVID-19 Vaccines
-
October 6, 2020
Int
PMDA to Offer Free Scientific Advice for COVID-19 Vaccines Development
-
August 4, 2020
Int
ICMRA meeting: COVID-19 Real-World Evidence and Observational studies #3
-
August 3, 2020
Int
ICMRA COVID-19 Treatments and Clinical Trials Workshop #2
-
June 19, 2020
Int
ICMRA statement about confidence in vaccine safety and effectiveness (for healthcare professionals)
-
June 19, 2020
Int
ICMRA statement about confidence in vaccines (for the general public)
-
June 4, 2020
Int
For Your Access to Japanese Clinical Trial/Clinical Research Information
-
May 20, 2020
Int
ICMRA statement on COVID-19
-
May 13, 2020
Int
First Approval of Antigen Test for COVID-19
-
May 12, 2020
Int
ICMRA meeting: COVID-19 Real-World Evidence and Observational studies #1
-
May 8, 2020
Int
Special Approval for Emergency on Remdesivir for COVID-19
-
April 21, 2020
Int
Four IVDs Approvals for COVID-19 and Response to the Increased Ventilator Demand
-
April 20, 2020
Int
Global regulatory workshop on COVID-19 therapeutic development #1
-
April 10, 2020
Int
PMDA Takes Further Steps to Speed up Clinical Development of COVID-19 Products
-
April 1, 2020
Int
Global regulatory workshop on COVID-19 vaccine development
-
March 31, 2020
Int
PMDA pledge to tackle COVID-19 Pandemic
-
October 31, 2019
Int
HBD East 2019 Think Tank Meeting
-
November 16, 2017
Int
Third tripartite meeting held between EMA, FDA and PMDA towards enhancing development for Antibacterial Agents posted
-
October 5, 2017
Int
HBD East 2017 Think Tank Meeting
-
February 10, 2016
Int
ICMRA's Zika Virus Disease Press Release
-
June 26, 2015
Int
PMDA International Strategic Plan 2015 announced
- Home
- International Activities
- What's New（International Activities）
International Activities